companydata.dkXGX Pharma ApS: Financial statements 2014
CVR: 32289290
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -14,436 compared with DKK 144,707 the year before. Equity amounted to DKK -144,865.
- Profit/Loss
- -14,436 kr.
- Equity
- -144,865 kr.
- Total Assets
- 466,272 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -14 t. | -145 t. | - |
| 2013 | - | 145 t. | 145 t. | 130 t. | - |
| 2012 | - | 84 t. | 96 t. | -14 t. | - |
Keep an eye on XGX Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
XGX Pharma ApS has published its annual report for 2013. Gross profit came to DKK 144,613, and the net result was DKK 144,707.
About XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The company is owned by Unimedic Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity amounted to DKK 30,787,180.